NDUFA13 Antikörper (AA 1-144)
Kurzübersicht für NDUFA13 Antikörper (AA 1-144) (ABIN2319241)
Target
Alle NDUFA13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-144
-
Kreuzreaktivität
- Human
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
-
Produktmerkmale
- NDUFA13 (NADH Dehydrogenase [Ubiquinone] 1 alpha Subcomplex Subunit 13, Cell Death Regulatory Protein GRIM-19, Complex I-B16.6, CI-B16.6, Gene Associated with Retinoic and Interferon-induced Mortality 19 Protein, GRIM-19, Gene Associated with Retinoic and IFN-induced Mortality 19 Protein, NADH-ubiquinone Oxidoreductase B16.6 Subunit, GRIM19, CDA016, CGI-39)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- Full length human NDUFA13, aa1-144 (AAH09189.1).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- NDUFA13 (NADH Dehydrogenase (Ubiquinone) 1 alpha Subcomplex, 13 (NDUFA13))
-
Andere Bezeichnung
- NDUFA13
-
Pathways
- Protein targeting to Nucleus, Negative Regulation of intrinsic apoptotic Signaling
Target
-